These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36656526)

  • 21. New properties of inclusion bodies with implications for biotechnology.
    Peternel S; Jevsevar S; Bele M; Gaberc-Porekar V; Menart V
    Biotechnol Appl Biochem; 2008 Apr; 49(Pt 4):239-46. PubMed ID: 17708747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refolding of inclusion body proteins from E. coli.
    Su Z; Lu D; Liu Z
    Methods Biochem Anal; 2011; 54():319-38. PubMed ID: 21954784
    [No Abstract]   [Full Text] [Related]  

  • 23. Intensification of Inclusion Body Processing via Temperature-Based Refolding.
    Wong RS; Alias NNM; Ong EBB; Liew MWO
    Methods Mol Biol; 2023; 2617():189-200. PubMed ID: 36656525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly efficient production of soluble proteins from insoluble inclusion bodies by a two-step-denaturing and refolding method.
    Yang Z; Zhang L; Zhang Y; Zhang T; Feng Y; Lu X; Lan W; Wang J; Wu H; Cao C; Wang X
    PLoS One; 2011; 6(7):e22981. PubMed ID: 21829569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inclusion Bodies: Status Quo and Perspectives.
    Kopp J; Spadiut O
    Methods Mol Biol; 2023; 2617():1-13. PubMed ID: 36656513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli.
    Wurm DJ; Quehenberger J; Mildner J; Eggenreich B; Slouka C; Schwaighofer A; Wieland K; Lendl B; Rajamanickam V; Herwig C; Spadiut O
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):667-676. PubMed ID: 29159587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pre-induction temperature affects recombinant HuGM-CSF aggregation in thermoinducible Escherichia coli.
    Restrepo-Pineda S; Sánchez-Puig N; Pérez NO; García-Hernández E; Valdez-Cruz NA; Trujillo-Roldán MA
    Appl Microbiol Biotechnol; 2022 Apr; 106(8):2883-2902. PubMed ID: 35412129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of viral neuraminidase from inclusion bodies produced by recombinant Escherichia coli.
    Lipničanová S; Chmelová D; Godány A; Ondrejovič M; Miertuš S
    J Biotechnol; 2020 Jun; 316():27-34. PubMed ID: 32302655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing the Yield of Active Recombinant Chitobiase by Physico-Chemical and In Vitro Refolding Studies.
    Dangi AK; Rishi P; Tewari R
    Protein J; 2016 Feb; 35(1):72-9. PubMed ID: 26831864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An efficient in vitro refolding of recombinant bacterial laccase in Escherichia coli.
    Mollania N; Khajeh K; Ranjbar B; Rashno F; Akbari N; Fathi-Roudsari M
    Enzyme Microb Technol; 2013 May; 52(6-7):325-30. PubMed ID: 23608500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent.
    Upadhyay V; Singh A; Jha D; Singh A; Panda AK
    Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refolding and simultaneous purification by three-phase partitioning of recombinant proteins from inclusion bodies.
    Raghava S; Barua B; Singh PK; Das M; Madan L; Bhattacharyya S; Bajaj K; Gopal B; Varadarajan R; Gupta MN
    Protein Sci; 2008 Nov; 17(11):1987-97. PubMed ID: 18780821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris.
    Zaremba-Czogalla M; Stumpp C; Bonifacio E; Paul R
    Protein Expr Purif; 2015 Jun; 110():65-71. PubMed ID: 25703052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refolding in the modern biopharmaceutical industry.
    Buscajoni L; Martinetz MC; Berkemeyer M; Brocard C
    Biotechnol Adv; 2022 Dec; 61():108050. PubMed ID: 36252795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioprocessing of recombinant proteins from
    Kachhawaha K; Singh S; Joshi K; Nain P; Singh SK
    Prep Biochem Biotechnol; 2023; 53(7):728-752. PubMed ID: 36534636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Refolding and purification of recombinant human granulocyte colony-stimulating factor from Escherichia coli by using protein folding liquid chromatography].
    Wang C; Wang L; Geng X
    Se Pu; 2007 Jul; 25(4):514-7. PubMed ID: 17970109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active protein aggregates produced in Escherichia coli.
    Peternel S; Komel R
    Int J Mol Sci; 2011; 12(11):8275-87. PubMed ID: 22174663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using High Pressure and Alkaline pH for Refolding.
    Morganti L; Chura-Chambi RM
    Methods Mol Biol; 2023; 2617():177-187. PubMed ID: 36656524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of recombinant pectate lyase refolded from inclusion bodies generated in E. coli BL21(DE3).
    Kumar S; Jain KK; Singh A; Panda AK; Kuhad RC
    Protein Expr Purif; 2015 Jun; 110():43-51. PubMed ID: 25497420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
    Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.